These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Calcium channel blockers are associated with improved survival and lower cardiovascular mortality in patients with renovascular disease. Deshmukh H, Barker E, Anbarasan T, Levin D, Bell S, Witham MD, George J. Cardiovasc Ther; 2018 Dec; 36(6):e12474. PubMed ID: 30372589 [Abstract] [Full Text] [Related]
4. Renal hemodynamics in essential and renovascular hypertension. Influence of captopril. Hollenberg NK. Am J Med; 1984 May 31; 76(5B):22-8. PubMed ID: 6328983 [Abstract] [Full Text] [Related]
5. Regulation of renal hemodynamics and glomerular filtration in patients with renovascular hypertension during converting enzyme inhibition with captopril. Textor SC, Tarazi RC, Novick AC, Bravo EL, Fouad FM. Am J Med; 1984 May 31; 76(5B):29-37. PubMed ID: 6328984 [Abstract] [Full Text] [Related]
6. Converting enzyme inhibitors and renal function in essential and renovascular hypertension. Mimran A, Ribstein J, DuCailar G. Am J Hypertens; 1991 Jan 31; 4(1 Pt 2):7S-14S. PubMed ID: 2009153 [Abstract] [Full Text] [Related]